David
Jiménez Castro
Profesor/a Titular Universidad
Charité
Berlín, AlemaniaPublicacions en col·laboració amb investigadors/es de Charité (20)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis
Thrombosis Research
2022
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
2021
-
A Comparison of GFR Calculated by Cockcroft-Gault vs. MDRD Formula in the Prognostic Assessment of Patients with Acute Pulmonary Embolism
Disease Markers, Vol. 2021
-
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial
The Lancet Haematology, Vol. 8, Núm. 9, pp. e627-e636
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Survival and quality of life after early discharge in low-risk pulmonary embolism
European Respiratory Journal, Vol. 57, Núm. 2
2020
-
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)
European Heart Journal, Vol. 41, Núm. 4, pp. 543-603
-
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: An international multicentre single-arm clinical trial
European Heart Journal, Vol. 41, Núm. 4, pp. 509-518
2019
-
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
European Respiratory Journal, Vol. 54, Núm. 3
-
Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries
Quality of Life Research, Vol. 28, Núm. 8, pp. 2111-2124
-
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial
Clinical Research in Cardiology, Vol. 108, Núm. 7, pp. 772-778
-
The Prognostic Value of Renal Function in Acute Pulmonary Embolism - A Multi-Centre Cohort Study
Thrombosis and Haemostasis, Vol. 119, Núm. 1, pp. 140-148
2018
-
Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: A systematic review and meta-analysis
European Heart Journal, Vol. 39, Núm. 47, pp. 4186-4195
-
Prognostic impact of copeptin in pulmonary embolism: A multicentre validation study
European Respiratory Journal, Vol. 51, Núm. 4
-
Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work
Thrombosis Research, Vol. 170, pp. 181-191
2017
-
Antiinflammatory therapy with canakinumab for atherosclerotic disease
New England Journal of Medicine, Vol. 377, Núm. 12, pp. 1119-1131
-
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study
Thrombosis and Haemostasis, Vol. 117, Núm. 12, pp. 2425-2434
2015
-
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry
Thrombosis Journal, Vol. 13, Núm. 1